The effects of pre- and post-exercise consumption of multi-ingredient performance supplements on cardiovascular health and body fat in trained men after six weeks of resistance training: a stratified, randomized, double-blind study

Table 4 Serum measurements

Variable	Group	n	Baseline	Post	Time	Group x Time
Triglycerides	MIPS	10	90.6 ± 27.1	118.5 ± 41.6	0.1124	0.571
mg/dL	Placebo	7	89.3 ± 26.9	102.9 ± 47.8
Total Cholesterol	MIPS	13	150.4 ± 31.4	145.0 ± 18.6	0.9464	0.273
mg/dL	Placebo	9	162.8 ± 47.5	167.6 ± 41.5
HDL	MIPS	13	44.5 ± 7.4	42.6 ± 8.2	0.3284	0.978
mg/dL	Placebo	11	45.0 ± 13.2	43.1 ± 6.6
LDL	MIPS	10	89.5 ± 29.0	82.7 ± 19.4	0.9253	0.201
mg/dL	Placebo	7	103.7 ± 29.7	109.5 ± 46.6
Non-HDL	MIPS	13	105.9 ± 30.0	101.2 ± 21.1	0.9725	0.249
mg/dL	Placebo	9	117.8 ± 47.6	122.2 ± 43.5
Glucose	MIPS	12	94.4 ± 4.0	97.1 ± 10.1	0.2655	0.821
mg/dL	Placebo	10	92.1 ± 10.4	94.0 ± 6.8
Cortisol	MIPS	13	123.4 ± 57.2	123.4 ± 65.8	0.5071	0.503
nmol/L	Placebo	11	116.2 ± 37.1	98.4 ± 31.5
Endogenous Nitrite	MIPS	13	5.3 ± 1.6	5.2 ± 1.1	0.9663	0.761
(μmol/L)	Placebo	11	5.3 ± 1.2	5.4 ± 1.4
Total Nitrite	MIPS	13	18.4 ± 18.5	17.9 ± 18.0	0.7688	0.957
(μmol/L)	Placebo	11	20.6 ± 20.6	20.2 ± 20.2
Nitrate	MIPS	13	13.1 ± 6.5	12.7 ± 11.0	0.7782	0.978
(μmol/L)	Placebo	11	15.3 ± 6.5	14.8 ± 9.1
Nitrate/Nitrite	MIPS	13	0.5 ± 0.4	0.7 ± 0.7	0.3325	0.629
	Placebo	11	0.4 ± 0.2	0.4 ± 0.3
hs-CRP	MIPS	11	1.0 ± 0.87	1.1 ± 0.97	0.1478	0.199
(mg/L)	Placebo	8	0.78 ± 0.89	2.1 ± 2.7

Data are mean ± SD. HDL, high-density lipoprotein; LDL, low-density lipoprotein; Non-HDL, total cholesterol minus HDL; hs-CRP, high-sensitivity C-reactive protein. MIPS, multi-ingredient performance supplement. Placebo, carbohydrate placebo. Sample size between each analyte is slightly different due technical difficulties with certain samples.